02146cam a2200433 i 4500001001300000003000600013005001700019008004100036010001500077040004500092042000800137043001200145050002100157074000900178086002900187099002900216110017900245245027400424246004700698246007200745264006000817264010100877300004500978336000801023337001601031338001901047490002301066500003601089500002501125504004101150610007001191650005301261650003401314655003301348776023401381810006001615949001801675999001901693on1012108564OCoLC20190109115227.0171117s2017    dcua     b   f000 0 eng c  a2017434973  aGPObengerdacGPOdDLCdOCLCFdGPOdMvI  apcc  an-us--- 4aKF26b.A644 2016  a10330 aY 4.AP 6/2:S.HRG.114-694  aY 4.AP 6/2:S.HRG.114-6941 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies,eauthor.10aPrioritizing public health :bthe FDA's role in the generic drug marketplace : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourteenth Congress, second session : special hearing, September 21, 2016, Washington, DC.30aFDA's role in the generic drug marketplace3 aFood and Drug Administration's role in the generic drug marketplace 1aWashington :bU.S. Government Publishing Office,c2017. 2aWashington, DC :bFor sale by the Superintendent of Documents, U.S. Government Publishing Office  aiii, 35 pages :billustrations ;c24 cm.  btxt  bn2rdamedia  bnc2rdacarrier1 aS. hrg. ;v114-694  aShipping list no.: 2018-0058-P.  aCRDP Program record.  aIncludes bibliographical references.10aUnited States.bFood and Drug AdministrationxRules and practice. 0aGeneric drugsxGovernment policyzUnited States. 0aDrugsxPriceszUnited States. 7aLegislative hearings.2lcgft08iMicrofiche version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.tPrioritizing public healthw(OCoLC)10454277281 aUnited States.bCongress.bSenate.tS. hrg. ;v114-694.  aBEVbFed Docs  c277423d277423